HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Parlux

This article was originally published in The Rose Sheet

Executive Summary

Fragrance manufacturer and distributor is interested in selling certain non-core lines and has engaged GLMAC, the intermediary behind the firm's letter of intent to sell Perry Ellis,to assist in the effort, company announces Sept. 6. "We currently have a number of product lines that have been successful but do not have the upside as other potential opportunities available to us," Parlux said, noting the sale of non-core licenses will help fund new fragrance ventures. In August, Parlux announced plans to sell Perry Ellis fragrance rights to Victory International for $140 mil. (1"The Rose Sheet" Aug. 21, 2006, In Brief). Parlux also holds fragrance licenses for the Paris Hilton,Guess?,XOXO and Ocean Pacific brands. Separately, Parlux reported fourth quarter (ended June 30) sales increased 21% to $40.8 mil., although the firm experienced a net loss of $14.1 mil. due to a non-cash, share-based compensation charge of $16.2 mil...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014204

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel